Overnight switch from levetiracetam to brivaracetam. Safety and tolerability
Brivaracetam is a newer antiseizure medication than levetiracetam. It has a more selective action on the synaptic vesicle glycoprotein 2A binding site, and it seems to provide a more favorable neuropsychiatric profile. The aim of this study was to assess the safety and tolerability of an overnight s...
Guardado en:
Autores principales: | L. Abraira, J. Salas-Puig, M. Quintana, I.M. Seijo-Raposo, E. Santamarina, E. Fonseca, M. Toledo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6d650cfbfe974b3c951bb5a60f53ba0b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A review of the pharmacology and clinical efficacy of brivaracetam
por: Klein P, et al.
Publicado: (2018) -
EFFICACY OF BRIVARACETAM IN PEDIATRIC EPILEPSY: AN UP-TO-DATE
por: Antonio Nicotera
Publicado: (2021) -
Can Overnight Sleep Efficiency Impact Cardiovascular Risk in the Morning? [Response to Letter]
por: Thosar SS, et al.
Publicado: (2021) -
Clinical and Economic Outcomes of Intravenous Brivaracetam Compared With Levetiracetam for the Treatment of Seizures in United States Hospitals
por: Silky Beaty, et al.
Publicado: (2021) -
Brivaracetam in the treatment of epilepsy: a review of clinical trial data
por: Feyissa AM
Publicado: (2019)